Webinar

Making Pulmonary Interventions Truly Personalized: From Treatment Development to Patient Care

Respiratory conditions can vary significantly from one patient to another. Therefore, when developing a new respiratory treatment, it is important to obtain a deep understanding of the pathology, and the effect that your treatment has on different patients. And after obtaining market clearance, clinicians must be able to define the most effective treatment plan for each individual patient.

Are you a medical device company that is developing a novel respiratory treatment, or that has a treatment solution on the market?

In this webinar recording you will discover how data-driven technologies like artificial intelligence can help to optimize respiratory treatment protocols, resulting in better clinical trial outcomes. And how clinicians benefit from smart patient screening and 3D planning tools to better prepare for treatments and achieve more predictable results.

This webinar is brought to you by Fluidda and Materialise, bringing together decades of expertise in advanced respiratory imaging and personalized 3D planning.

Our collaborative effort will provide you with guidance from beginning to end in your product lifecycle. Practically, this entails support from the R&D phase, tuning the medical intervention to specific pathophysiology and patient phenotypes, all the way to the clinical roll-out of personalized treatment planning for clinicians. This could reduce the time from development to roll-out in clinical practice and optimize treatment success.

What you will learn

  • How advanced CT analysis techniques uncover a deeper understanding of lung pathology and disease progression to define and optimize treatment parameters for your device
  • How smart patient screening and 3D treatment planning can lead to more successful clinical trials, trial time reduction, and a guarantee of predictable outcomes
  • How to cost-effectively scale your treatment planning when going from helping one patient to millions more

Speakers


Share on:

Share on Facebook
Share on Twitter
Share on LinkedIn
Share with Pocket

Materialise medical device software may not be available in all markets because product availability is subject to the regulatory or medical practices in individual markets. In countries where no regulatory registration is obtained of Mimics or 3-matic Medical, a research version is available. Please contact your Materialise representative if you have questions about the availability of Materialise medical device software in your area.

Materialise medical device software may not be available in all markets because product availability is subject to the regulatory and/ or medical practices in individual markets. In countries where no regulatory registration is obtained of Mimics and/or 3-matic Medical, a research version is available. Please contact your Materialise representative if you have questions about the availability of Materialise medical device software in your area. L-102297

You might also like

More inspiration